
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
5 Aug 202545min

Artificial Intelligence (AI) and Lung Cancer Treatment Decisions
Artificial Intelligence (AI) and Lung Cancer Treatment Decisions by IASLC
5 Aug 202545min

LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania
LCC in Romanian: Management of Unresectable, EGFR-mutated Stage III Lung Cancer in Romania by IASLC
2 Aug 202547min

IASLC - Stigma
IASLC - Stigma by IASLC
29 Jul 202557min

LCC in Japanese: ASCO 2025 Highlights
LCC in Japanese: ASCO 2025 Highlights by IASLC
25 Jul 202534min

Preview: IASLC | ASCO 2025 North American Conference on Lung Cancer
On December 5, 2025, we will kick off the IASLC ASCO 2025 North America Conference on Lung Cancer. Guest include Dr. Ramesh Rengan, the Peter Wootton Professor and Chair of Radiation Oncology at the ...
23 Jul 202522min

FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC
FDA Approval: Datopotamab Deruxtecan for EGFR NSCLC by IASLC
18 Jul 202545min

FDA Approval: Sunvozertinib for EGFR Exon 20
FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC
15 Jul 202541min


















